* Represents sales to collaboration partners of products manufactured by BioNTech and reflects manufacturing costs and variances to the extent identified.
** No granular information available for this year.
In 2024, total commercial revenues of biotech company BioNTech SE stood at some 2.75 billion euros, of which 2.43 billion were due to the COVID-19 vaccine. This statistic illustrates the commercial revenues of BioNTech SE worldwide from 2017 to 2024, by type. On November 9th, 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
BioNTech, & U.S. Securities and Exchange Commission. (March 10, 2025). Commercial revenues of BioNTech SE from 2022 to 2024, by type (in million euros) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 20, 2026, from /statistics/1300599/commercial-revenues-by-type-biontech/
BioNTech, und U.S. Securities and Exchange Commission. "Commercial revenues of BioNTech SE from 2022 to 2024, by type (in million euros)." Chart. March 10, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 20, 2026. /statistics/1300599/commercial-revenues-by-type-biontech/
BioNTech, U.S. Securities and Exchange Commission. (2025). Commercial revenues of BioNTech SE from 2022 to 2024, by type (in million euros). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 20, 2026. /statistics/1300599/commercial-revenues-by-type-biontech/
BioNTech, and U.S. Securities and Exchange Commission. "Commercial Revenues of Biontech Se from 2022 to 2024, by Type (in Million Euros)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 10 Mar 2025, /statistics/1300599/commercial-revenues-by-type-biontech/
BioNTech & U.S. Securities and Exchange Commission, Commercial revenues of BioNTech SE from 2022 to 2024, by type (in million euros) ÌÇÐÄÆƽâ°æ, /statistics/1300599/commercial-revenues-by-type-biontech/ (last visited July 20, 2026)
Commercial revenues of BioNTech SE from 2022 to 2024, by type (in million euros) [Graph], BioNTech, & U.S. Securities and Exchange Commission, March 10, 2025. [Online]. Available: /statistics/1300599/commercial-revenues-by-type-biontech/
